血液採集市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球血液採集市場價值為 102 億美元，預計到 2034 年將以 6.1% 的複合年成長率成長至 183 億美元。市場擴張的動力來自慢性病和傳染病負擔的加重、技術的快速創新、外科手術數量的增加以及老齡人口的增加。隨著醫療服務提供者優先考慮安全、準確和高效的血液樣本採集以用於診斷、治療和研究，對先進血液採集解決方案的需求正在增加。血液採集設備是臨床工作流程中的關鍵工具，可確保在確保病人安全的前提下精確採集血液樣本。這些設備廣泛應用於醫院、診斷實驗室和血庫，是各種醫療檢測流程的支柱。市場也見證了對簡化操作、降低污染風險和改善患者體驗的系統的投資增加，這進一步鞏固了其長期成長軌跡。

依產品類型分類，市場分為系統和耗材。耗材領域在2024年佔據最大佔有率，達到76.7%，這得益於其在持續準確採集樣本方面發揮的重要作用。預計到2034年，該領域的市場規模將超過139億美元，預測期內的複合年成長率為6%。另一方面，系統領域預計在2025年至2034年間以略高的複合年成長率（6.3%）成長，這得益於擴大採用旨在提高營運效率和患者舒適度的整合解決方案。醫療保健提供者越來越青睞旨在提高診斷準確性和降低操作風險的系統，這進一步增強了該領域的發展勢頭。

根據採血方法，市場細分為手動採血和自動採血。 2024年，手動採血佔總市場的53.2%，其成長得益於其成本效益、可用性以及在各種臨床環境中的易用性。手動採血方法仍然是全球醫療保健實踐的重要組成部分，依靠訓練有素的專業人員進行精準的樣本提取。該過程通常涉及使用針頭或真空系統等客製化設備，以滿足特定患者和檢測需求，確保在不同環境下的可靠性。

從應用角度來看，市場分為診斷、治療和研究。 2024年，診斷仍佔據主導地位，市佔率達50.6%，這得益於依賴血液樣本進行疾病檢測、監測和預防的檢測數量不斷增加。對早期精準診斷健康狀況的需求不斷成長，刺激了對先進血液採集系統的需求，這反過來又加速了該領域的成長。

從區域來看，北美在2024年以35.4%的佔有率領先全球採血市場，這得益於其強大的醫療基礎設施、日益​​成長的慢性病病例以及大量的診斷檢測。該地區也受益於創新採血技術的快速普及以及對提高診斷速度和準確性的重視。在該地區，美國仍然是主要貢獻者，市場規模從2023年的31億美元成長到2024年的32億美元。對高品質診斷服務的持續需求，加上採血方法的持續改進，預計將使美國在整個預測期內保持領先地位。

影響競爭格局的關鍵參與者包括賽默飛世爾科技、泰爾茂公司、麥克森公司、Haemonetics公司、雅培實驗室、凱傑公司、費森尤斯公司、莎施泰特公司、格萊納公司、FL MEDICAL公司、碧迪公司、康德樂公司、羅氏公司、Streck公司、西門子醫療公司和尼普羅公司。這些公司始終致力於推動產品創新，增強全球影響力，並提供滿足全球醫療保健提供者不斷變化的需求的解決方案。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 慢性病和傳染病發生率上升
    • 血液採集技術的進步
    • 外科手術數量不斷增加
    • 老年人口不斷增加
  • 產業陷阱與挑戰
    • 輸血相關風險
    • 缺乏熟練的醫療保健專業人員
  • 市場機會
    • 政府主導的提倡捐血和疾病篩檢的活動日益增多
• 成長潛力分析
• 監管格局
  • 北美洲
  • 歐洲
• 技術格局
• 未來市場趨勢
• 差距分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板
• 關鍵進展
  • 併購
  • 夥伴關係和合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：依產品類型，2021 - 2034 年

• 主要趨勢
• 系統
  • 自動化系統
  • 手動系統
• 耗材
  • 靜脈
    • 針頭和注射器
      • 雙頭針
      • 帶翼採血套裝
      • 標準皮下注射針
      • 其他採血針
    • 採血管
      • 血清分離
      • 乙二胺四乙酸
      • 肝素
      • 血漿分離
    • 血袋
    • 其他靜脈產品
  • 毛細管
    • 刺血針
    • 微容器管
    • 微量血球容積比管
    • 加溫裝置
    • 其他毛細管產品

第6章：市場估計與預測：依方法，2021 - 2034 年

• 主要趨勢
• 手動採血
• 自動採血

第7章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 診斷
• 治療
• 研究

第8章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院和診所
• 診斷中心
• 血庫
• 學術和研究機構

第9章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• Abbott Laboratories
• Becton, Dickinson, and Company
• Cardinal Health
• F. Hoffmann-La Roche
• FL MEDICAL
• Fresenius SE & Co
• Greiner
• Haemonetics Corporation
• McKesson Corporation
• Nipro Corporation
• QIAGEN
• Sarstedt AG & Co
• Siemens Healthineers
• Streck
• Terumo Corporation
• Thermo Fisher Scientific

The Global Blood Collection Market was valued at USD 10.2 billion in 2024 and is estimated to grow at a CAGR of 6.1% to reach USD 18.3 billion by 2034. Market expansion is being driven by the growing burden of chronic and infectious diseases, rapid technological innovation, a higher volume of surgical procedures, and a rising elderly population. The demand for advanced blood collection solutions is increasing as healthcare providers prioritize safe, accurate, and efficient sample collection for diagnostics, treatment, and research. Blood collection devices are critical tools in clinical workflows, ensuring that blood samples are obtained with precision and patient safety in mind. These devices are widely used in hospitals, diagnostic laboratories, and blood banks, serving as the backbone of various medical testing processes. The market is also witnessing greater investment in systems that streamline operations, reduce contamination risk, and improve patient experience, further reinforcing its long-term growth trajectory.

By product type, the market is divided into systems and consumables. The consumables segment held the largest share at 76.7% in 2024, driven by its essential role in consistent and accurate sample collection. This segment is expected to reach over USD 13.9 billion by 2034, advancing at a CAGR of 6% during the forecast period. Systems, on the other hand, are forecast to grow at a slightly higher CAGR of 6.3% between 2025 and 2034, supported by the rising adoption of integrated solutions that improve operational efficiency and patient comfort. Healthcare providers are increasingly favoring systems designed to enhance diagnostic accuracy and reduce procedural risks, adding to the segment's momentum.

Based on method, the market is segmented into manual and automated blood collection. Manual blood collection accounted for 53.2% of the total market in 2024, with growth supported by its cost-effectiveness, availability, and ease of use in various clinical environments. This approach continues to be a key component of healthcare practices worldwide, relying on trained professionals to perform accurate sample extraction. The process typically involves using tailored devices such as needles or vacuum systems to meet specific patient and test requirements, ensuring reliability in diverse settings.

In terms of application, the market is categorized into diagnostics, treatment, and research. Diagnostics remained the dominant segment in 2024 with a 50.6% share, fueled by the growing number of tests that depend on blood samples for disease detection, monitoring, and prevention. Rising demand for early and precise identification of health conditions is spurring the need for advanced blood collection systems, which in turn is accelerating the segment's growth.

Regionally, North America led the global blood collection market with a 35.4% share in 2024, underpinned by a strong healthcare infrastructure, increasing cases of chronic illnesses, and a high volume of diagnostic testing. The region also benefits from the rapid adoption of innovative blood collection technologies and an emphasis on improving diagnostic speed and accuracy. Within the region, the United States remains the primary contributor, with the market size growing from USD 3.1 billion in 2023 to USD 3.2 billion in 2024. Consistent demand for high-quality diagnostic services, supported by continuous improvements in blood collection methodologies, is expected to sustain the country's leadership position throughout the forecast period.

Key players influencing the competitive landscape include Thermo Fisher Scientific, Terumo Corporation, McKesson Corporation, Haemonetics Corporation, Abbott Laboratories, QIAGEN, Fresenius SE & Co, Sarstedt AG & Co, Greiner, FL MEDICAL, Becton, Dickinson and Company, Cardinal Health, F. Hoffmann-La Roche, Streck, Siemens Healthineers, and Nipro Corporation. These companies are consistently focused on driving product innovation, strengthening their global reach, and delivering solutions that meet the changing requirements of healthcare providers across the world.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product type
  • 2.2.3 Method
  • 2.2.4 Application
  • 2.2.5 End use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic and infectious diseases
    • 3.2.1.2 Advancements in blood collection technologies
    • 3.2.1.3 Increasing number of surgical procedures
    • 3.2.1.4 Rising geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Risks associated with blood transfusions
    • 3.2.2.2 Lack of skilled healthcare professionals
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rising government-led campaigns for promoting blood donation and disease screening
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard
• 4.7 Key developments
  • 4.7.1 Mergers and acquisitions
  • 4.7.2 Partnerships and collaborations
  • 4.7.3 New product launches
  • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 System
  • 5.2.1 Automated systems
  • 5.2.2 Manual systems
• 5.3 Consumables
  • 5.3.1 Venous
    • 5.3.1.1 Needles and syringes
      • 5.3.1.1.1 Double-ended needles
      • 5.3.1.1.2 Winged blood collection sets
      • 5.3.1.1.3 Standard hypodermic needles
      • 5.3.1.1.4 Other blood collection needles
    • 5.3.1.2 Blood collection tubes
      • 5.3.1.2.1 Serum-separating
      • 5.3.1.2.2 EDTA
      • 5.3.1.2.3 Heparin
      • 5.3.1.2.4 Plasma-separating
    • 5.3.1.3 Blood bags
    • 5.3.1.4 Other venous products
  • 5.3.2 Capillary
    • 5.3.2.1 Lancets
    • 5.3.2.2 Micro-container tubes
    • 5.3.2.3 Micro-hematocrit tubes
    • 5.3.2.4 Warming devices
    • 5.3.2.5 Other capillary products

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Manual blood collection
• 6.3 Automated blood collection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Diagnostics
• 7.3 Treatment
• 7.4 Research

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 1.1 Key trends
• 1.2 Hospitals and clinics
• 1.3 Diagnostic centers
• 1.4 Blood banks
• 1.5 Academic and research institutes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 1.5.1 U.S.
  • 1.5.2 Canada
• 9.3 Europe
  • 1.5.3 Germany
  • 1.5.4 UK
  • 1.5.5 France
  • 1.5.6 Spain
  • 1.5.7 Italy
  • 1.5.8 Netherlands
• 9.4 Asia Pacific
  • 1.5.9 China
  • 1.5.10 Japan
  • 1.5.11 India
  • 1.5.12 Australia
  • 1.5.13 South Korea
• 9.5 Latin America
  • 1.5.14 Brazil
  • 1.5.15 Mexico
  • 1.5.16 Argentina
• 9.6 Middle East and Africa
  • 1.5.17 South Africa
  • 1.5.18 Saudi Arabia
  • 1.5.19 UAE

Chapter 10 Company Profiles

• 10.1 Abbott Laboratories
• 10.2 Becton, Dickinson, and Company
• 10.3 Cardinal Health
• 10.4 F. Hoffmann-La Roche
• 10.5 FL MEDICAL
• 10.6 Fresenius SE & Co
• 10.7 Greiner
• 10.8 Haemonetics Corporation
• 10.9 McKesson Corporation
• 10.10 Nipro Corporation
• 10.11 QIAGEN
• 10.12 Sarstedt AG & Co
• 10.13 Siemens Healthineers
• 10.14 Streck
• 10.15 Terumo Corporation
• 10.16 Thermo Fisher Scientific